Welcome Message

山中 寿

President of the 63rd Annual General Assembly and
Scientific Meeting of the Japan College of Rheumatology
Hisashi Yamanaka, M.D., Ph.D.
Professor of Rheumatology, Tokyo Women’s Medical University

The 63rd Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology will be held at Kyoto International Conference Center and Grand Prince Hotel Kyoto for three days from April 15 to 17, 2019. I am honored to serve as the president for the coming assembly and meeting of our long-established society. I would like to ask for your support in making the congress a wonderful opportunity for all the participants to enhance their research.

I propose the main theme of this congress as “Talk about the future .”

In the past two decades, there have been remarkable advances in rheumatology, resulting in dramatically improved therapeutic outcomes. While rheumatoid arthritis has long been considered a common intractable disease, its long-term prognosis has been improved considerably by starting appropriate treatment early after onset. Thinking back on the situation 20 years ago, remission was just a “dream,” but it has now become a feasible reality.

What are the future “dreams” we want to achieve?

Even when told that they have achieved remission, the patient is not truly satised. The patient wants to be rid of his or her illness, whatever the disease may be. Can rheumatic diseases such as rheumatoid arthritis and collagen disease be cured? Is it possible to prevent their onset, and to repair deformed joints? In fact, a great many issues remain to be resolved in rheumatology, including those we now consider unsolvable. However, we cannot meet the needs of our patients without setting specic goals.

The remarkable advances in rheumatology in the past two decades have been occurring with the progress of evidence-based medicine (EBM). As the importance of evidence is recognized increasingly, a realistic goal of medicine is to secure better evidence. I suspect that we are now suffering nearsightedness as we set an easily achievable goal and are satised with merely attaining it, and that we may be unable to dream of true “dreams.”

I would like to ask speakers to talk about their “dreams” at the 63rd congress.

Science and technology will continue to evolve. As demonstrated by the fact that remission, which was considered impossible 20 years ago, has become a reality, even currently unachievable goals may be attained some time in the future. Accordingly, we must have a “dream.”

What are the “dreams” we want to realize? The forthcoming congress will provide a good opportunity for all the participants to discuss their “dreams” with others about the way to the dream and the state of progress. In particular, I hope young researchers responsible for the next generation should take part in the congress and pave the way to the future of rheumatology with their potential for realizing “dreams.”

I look forward to welcoming you heartily.

Page top

Copyright © The 63rd Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology. All Rights Reserved.